McCracken Joseph S
- SEC CIK
- 0001632454
No open-market purchases or sales filed in the past year.
Current role at each company
- SVRA Savara IncDirectoras of Feb 17, 2026
- LUMO Lumos Pharma, Inc.Directoras of Dec 13, 2024
- KIN Kindred Biosciences, Inc.Directoras of Aug 30, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists McCracken Joseph S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SVRA Savara Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2025 (view filing) | May 29 | 4 days | McCracken Joseph SDirector | PPurchase | +10.0K | $2.08 | +$20.8K | +4.0%260.8K after | |
| Nov 20, 2024 (view filing) | Nov 19 | 1 day | McCracken Joseph SDirector | PPurchase | +20.0K | $2.95 | +$59.0K | +10.5%210.8K after |
LUMO Lumos Pharma, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2022 (view filing) | Nov 16 | 2 days | McCracken Joseph SDirector | PPurchase | +4.00K | $5.03 | +$20.1K | +34.1%15.7K after | |
| Aug 26, 2022 (view filing) | Aug 25 | 1 day | McCracken Joseph SDirector | PPurchase | +3.17K | $8.60 | +$27.3K | +37.1%11.7K after | |
| Aug 13, 2021 (view filing) | Aug 11 | 2 days | McCracken Joseph SDirector | PPurchase | +7.47K | $7.55 | +$56.4K | +694.7%8.55K after |